🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yalun Li

Zhejiang Chinese Medical University

ORCID: 0000-0002-9052-8209

Also affiliated with China National Nuclear Corporation, Sichuan University, Sir Run Run Shaw Hospital, West China Hospital of Sichuan University, Sichuan Cancer Hospital, East China University of Technology, Changhua Christian Hospital, Hangzhou Medical College

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.752Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Efficient and Accurate Extracting of Unstructured EHRs on Cancer Therapy Responses for the Development of RECIST Natural Language Processing Tools: Part I, the Corpus

JCO Clinical Cancer Informatics(2020)10.1200/cci.19.00147
Top 27%
0.752DataRank
Top 27%11 citations

Yung‐Hung Luo, Jason A. Wampfler, Samuel M. Rubinstein, Firat Tiryaki, Ashok Kumar +4 more

Papers

Driven by 5 papers — median percentile 73. Top paper: “Efficient and Accurate Extracting of Unstructured EHRs on Cancer Therapy Responses for the Development of RECIST Natural Language Processing Tools: Part I, the Corpus”.

Efficient and Accurate Extracting of Unstructured EHRs on Cancer Therapy Responses for the Development of RECIST Natural Language Processing Tools: Part I, the Corpus

JCO Clinical Cancer Informatics(2020)10.1200/cci.19.00147
Top 27%
0.752DataRank
Top 27%11 citations

Yung‐Hung Luo, Jason A. Wampfler, Samuel M. Rubinstein, Firat Tiryaki, Ashok Kumar +4 more

Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101078
N/A
0.692DataRank · unranked
100 citations

Zhen Zeng, Yang Jin, Lan Yang, Ting Fan, Zhoufeng Wang +14 more

Clinical outcomes of stage-IV non–small-cell lung cancer in young patients and the impact of tumor markers

Cancer Treatment and Research Communications(2023)10.1016/j.ctarc.2023.100723
N/A
0.208DataRank · unranked
3 citations

Yalun Li, Vinicius Ernani, Jonathan D’Cunha, Marie‐Christine Aubry, Ping Yang +1 more

Osimertinib in previously EGFR-TKI treated non-small cell lung cancer (NSCLC) patients without T790M mutation: Real-world evidence.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21631
N/A
0DataRank · unranked
0 citations

Han Liu, Jason A. Wampfler, Henry D. Tazelaar, Yalun Li, Tobias Peikert +7 more

Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation

Journal of Cancer Research and Clinical Oncology(2021)10.1007/s00432-021-03766-5
N/A
0DataRank · unranked
7 citations

Han Liu, Jason A. Wampfler, Henry D. Tazelaar, Yalun Li, Tobias Peikert +7 more